A Blinded, Randomized, Intra-individual, Vehicle-controlled and Multi-centre Study of Photodynamic Therapy With MAL Cream in Patients With Skin Type V or VI With Acne Vulgaris

NCT00673933 Phase 2 COMPLETED Results posted

In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.

Details

Lead sponsor	Photocure
Phase	Phase 2
Status	COMPLETED
Enrolment	20
Start date	2008-05
Completion	2008-12

Conditions

• Acne Vulgaris

Interventions

• Methyl aminolevulinate (MAL) PDT

Primary outcomes

• Proportion of Patients With Moderate to Severe Hypopigmentation and Hyperpigmentation Assessed After Treatment — 4 weeks after last treatment, 6 weeks after baseline

Countries

United States